Molecular pathology of fatal familial insomnia

Brain Pathology

Volumn 8, Issue 3, 1998, Pages 539-548

  Parch, Piero ^a   Petersen, Robert B ^a   Chen, Shu G ^a   Autilio Gambetti, L ^a   Capellari, Sabina ^a   Monari, Lucia ^b   Cortelli, Pietro ^b   Montagna, Pasquale ^b   Lugaresi, Elio ^b   Gambetti, Pierluigi ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PRION PROTEIN;

CLINICAL FEATURE; CONFERENCE PAPER; CREUTZFELDT JAKOB DISEASE; FATAL FAMILIAL INSOMNIA; GENE MUTATION; HETEROZYGOSITY; NEUROPATHOLOGY; PHENOTYPE; PROTEIN ANALYSIS; PROTEIN CONFORMATION; SYNDROME DELINEATION; THALAMUS;

EID: 7144253121     PISSN: 10156305     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1750-3639.1998.tb00176.x     Document Type: Conference Paper

References (34)

1. Baker HF, Poulter M, Crow TJ, Frith CD, Lofthouse R, Ridley RM, Coliinge J. (1991) Amino acid polymorphism in human prion protein and age at death in inherited prion disease. Lancet 337: 1286.
2. Bessen RA, Marsh RF (1992). Biochemical and physical properties of the prion protein from two strains of the transmissible mink encephalopathy agent. J Virol 66: 2096-2101.
3. Brown P, Kenney K, Little B, Ironside J, Will R, Cervenakova L, Bjork RJ, San Martin RA, Safar J, Roos R, Haltia M, Gibbs CJ,Jr, and Gajdusek DC. (1995). Intracerebral distribution of infectious amyloid protein in spongiform encephalopathy. Ann Neurol 38: 245-253.
4. Bruce ME. Strain typing studies of scrapie and BSE (1996). In: Methods in Molecular Medicine: Prion Diseases. Baker H, Ridley RM (eds), Humana Press Inc., pp. 223-236.
5. Caughey B, Race RE, Ernst D, Buchmeier MJ, Chesebro B (1989). Prion protein biosynthesis in scrapie-infected and uninfected neuroblastoma cells, J Virol 63:175-181.
6. Chen SG, Teplow DB, Parchi P, Teller JK, Gambetti P, Autilio-Gambetti L (1995). Truncated forms of the human prion protein in normal brain and in prion diseases. J Biol Chem 270: 19173-19180.
7. Chen SG, Parchi P, Brown P, Capellari S. Zou W, Cochran EJ, Vnencak-Jones CL, Julien J, Vital C, Mikol J, Lugaresi E, Autilio-Gambetti L, Gambetti P (1997). Allelic origin of the abnormal prion protein isoform in familial prion diseases. Nat Med 3:1009-1015.
8. Cortelli P, Perani D, Parchi P, Grassi F, Montagna P, De Martin M, Castellani R, Tinuper R Gambetti P, Lugaresi E, Fazio F (1997). Cerebral metabolism in fatal familial insomnia: Relation to duration, neuropathology, and distribution of protease-resistant prion protein. Neurology 49:126-133.
9. Dlouhy SR, Hsiao K, Farlow MR, Foroud T, Conneally PM, Johnson P, Prusiner SB, Hodes ME, Ghetti B (1992). Linkage of the Indiana kindred of Gerstmann-StrãusslerScheinker disease to the prion protein gene. Nat Genet 1: 64-67.
10. Gabizon R, Telling G, Meiner Z, Halimi M, Kahana I, Prusiner SB (1996). Insoluble wild-type and proteaseresistant mutant prion protein in brains of patients with inherited prion diseases. Nat Med 2: 59-64.
11. Goldfarb LG, Brown P, Goldgaber D (1989). Patients with Creutzfeldt-Jakob disease and kuru lack the mutation in the PRNP gene found in Gerstmann-Sträussler Scheinker syndrome, but they show a different double-allele mutation in the same gene. Am J Hum Genet 45: (SuppL): A189.
12. Goldfarb LG, Haltia M, Brown P, Nieto A, Kovanen J, McCombie WR, Trapp S, Gajdusek DC (1991). New mutation in scrapie amyloid precursor gene (at codon 178) in Finnish Creutzfeldt-Jakob kindred. Lancet 337: 425.
13. Goldfarb LG, Petersen RB, Tabaton M, Brown P. LeBlanc AC, Montagna P, Cortelli P, Julien J, Vital C, Pendlebury WW, Haltia M, Willis PR, Hauw JJ, McKeever PE, Monari L, B Schrank, Swergold GD, Autilio-Gambetti L, Gajdusek DC, Lugaresi E, Gambetti P (1992). Fatal familial insomnia and Familial Creutzfeldt Jakob disease: disease phenotype determined by a DMA polymorphism. Science 258: 806-808.
14. Jarius C, Hainfellner JA, Kitamoto T, Parchi P, Gambetti P, Budka H (1998). Familial Creutzfeldt-Jakob disease with PRNP codon E200K mutation: valine homozygosity in codon 129 and type 2 PrPres (in press).
15. Lugaresi E, Medori R, Montagna P, Baruzzi A, Cortelli P, Lugaresi A, Tinuper P, Zucconi M, Gambetti P (1986). Fatal familial insomnia and dysautonomia with selective degeneration of thalamic nuclei. New Engl J Med 315: 997-1003.
16. Manetto V, Medori R, Cortelli P, Montagna P, Baruzzi A, Hauw JJ, Rancurel G, Vanderhaeghen JJ, Mailleux P, Bugiani O, Tagliavini F, Bouras C, Rizzuto N, Lugaresi E, Gambetti P (1992). Fatal familial insomnia. Clinical and pathological study of five new cases. Neurology 42: 312-319.
17. Medori R, Tritschler HJ, LeBlanc A, Villare F, Manetto V, Chen HY, Xue R, Leal S, Montagna P, Cortelli P, Tinuper P, Avoni P, Mochi M, Baruzzi A, Hauw JJ, Ott J, Lugaresi E, Autilio-Gambetti L, Gambetti P. Fatal familial insomnia is a prion disease with a mutation at codon 178 of the prion protein gene New Engl J Med 326: 444-449.
18. Monari L, Chen SG, Brown P, Parchi P, Petersen KB, Mitol J, Gray F, Cortelli P, Montagna P, Ghetti B, Goldfarb LG, Gajdusek DC. Lugaresi E, Gambetti P, AutilioGambetti L (1994). Fatal Familial Insomnia and familial Creutzfeldt-Jakob disease: Different prion proteins determined by a DNA polymorphism. Proc Natl Acad Sci USA, 91: 2839-2842.
19. Nieto A, Goldfarb LG, Brown P, McCombie WR, Trapp S, Asher DM, Gajdusek DC (1991). Codon 178 mutation in ethnically diverse Creutzfeldt-Jakob disease families. Lancet 337:622-623.
20. Palmer MS, Dryden AJ, Hughes JT, Coilinge J (1991). Homozygous prion protein genotype predisposes to sporadic Creutzfeldt-Jakob disease. Nature 352: 340-342.
21. Palmer MS, Mahal SP, Campbell TA, Hill AF, Sidle KC, Laplanche JL, Coilinge J (1993). Deletions in the prion protein gene are not associated with CJD. Hum Mol. Genet. 2: 541-544.
22. Parchi P, Castellani R, Cortelli P, Montagna P, Chen SG, Petersen RB, Manetto V, Vnencak-Jones CL, McLean MJ, Sheller JR, Lugaresi E. Autilio-Gambetti L, Gambetti P (1995). Regional distribution of protease-resistant prion protein in Fatal Familial Insomnia. Ann Neurol 38: 21-29.
23. Parchi P, Castellani R, Capellan S, Ghetti B, Young K, Chen SG, Farlow M, Dickson DW, Sima AAF, Trojanowski JQ, Petersen RB, Gambetti P (1996). Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease. Ann Neurol 39: 767-778.
24. Parchi P, Capellan S, Chen SG, Ghetti B, Mikol J, Vital C, Cochran E, Trojanowski JQ. Dickson DW, Petersen RB, Gambetti P (1996). Similar posttranslational modifications of the prion protein in familial, sporadic and iatrogenic Creutzfeldt-Jakob disease. Soc Neurosci Abstr 711.
25. Parchi P, Capellari S, Chen SG, Petersen RB, Gambetti P, Kopp N, Brown P, Kitamoto T, Tateishi J, Giese A, Kretzschmar H (1997). Typing prion isoforms. Nature 386: 232-234.
26. Parchi P, Piccardo P. Gambetti P, Ghetti B. Human Prion Diseases (1998). In: Progress in Pathology 4, (eds.) Kirkham N, and Lemoine NR. Churchill Livingstone, Edimburgh. pp 39-77
27. Petersen RB, Parchi P, Richardson SL, Urig CB, Gambetti P (1996). Effect of the D178N mutation and the codon 129 polymorphism on the metabolism of the prion protein. J Biol Chem 271, 12661-12668.
28. Prusiner SB, McKinley MP. Bowman KA, Bolton DC, Bendheim PE, Groth DF, Glenner GG (1983). Scrapie prions aggregate to form amyloid-like birefringent rods. Cell 35: 349-358.
29. Riek R. Liemann S, Wider G, Billeter M, Hornemann S, Glockshuber R. Wuthrick K. Prion Protein NMR structure and familial human transmissible spongiform encephalopathies, J Mol Biol (in press)
30. Silvestrin MC, Cardone F. Maras B, Pucci P. Barra D, Brunon M, Pocchiari M (1997). Identification of the prion protein allotypes which accumulate in the brain of sporadic and familial Creutzfeldt-Jakob disease patients. Nat Med 3:521-525.
31. Tagliavini F, Prelli F, Porro M, Rossi G, Giaccone G, Farlow MR, Dlouhy SR, Ghetti B, Bugiani O, Frangione B. (1994) Amyloid fibrils in Gerstmann-Straussler-Scheinker disease (Indiana and Swedish kindreds) express only PrP peptides encoded by the mutant allele Cell 79: 695-703.
32. Taraboulos A, Scott M, Semenov A, Avrahami D, Laszlo L, Prusiner SB (1995). Cholesterol depletion and modification of COOH-terminal targeting sequence of the prion protein inhibit formation of the scrapie isoform. J Cell Biol 129: 121-132.
33. Telling GC, Parchi P, DeArmond SJ, Cortelli P, Montagna P, Gabizon R, Mastrianni J, Lugaresi E, Gambetti P, Prusiner SB (1996). Evidence for the conformation of the pathologic isoform of the prion protein enciphering and propagating prion diversity. Science 274: 2079-2082.
34. Young K, Clark HB, Piccardo P, Dlouhy SR, Ghetti B (1997). Gerstmann-Sträussler-Scheinker disease with the PRNP P102L mutation and valine at codon 129. Mol Brain Res 44: 147-150.